{
    "2020-05-29": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Alan Fournier Adds 4 Stocks to Portfolio",
                "features": {
                    "keywords": [
                        "Alan Fournier",
                        "Portfolio",
                        "Stocks"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "J&J's Ebola vaccine wins EU regulatory panel backing",
                "features": {
                    "keywords": [
                        "J&J",
                        "Ebola",
                        "vaccine",
                        "EU",
                        "regulatory",
                        "backing"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "European agency panel recommends approval of J&J's Ebola vaccine",
                "features": {
                    "keywords": [
                        "European",
                        "agency",
                        "panel",
                        "approval",
                        "J&J",
                        "Ebola",
                        "vaccine"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}